Division of Research Spotlight
The Kaiser Permanente Division of Research conducts, publishes, and disseminates epidemiologic and health services research to improve the health and medical care of Kaiser Permanente members and society at large. We seek to understand the determinants of illness and well-being, and to improve the quality and cost-effectiveness of health care. Currently, DOR’s 550-plus staff is working on more than 350 epidemiological and health services research projects.
Early career researcher Marvin Langston, PhD, MPH, studies potential links between infections, inflammation, and cancer as well as racial/ethnic and sexual minority health disparities.
Kaiser Permanente researchers showed starting annual colorectal cancer screening at age 45 in African Americans can find colorectal cancers at a rate similar to that seen when screening starts after age 50 — the age most guidelines currently recommend.
A new prostate cancer risk calculator developed by Kaiser Permanente Northern California researchers may help men going through prostate cancer screening decide whether to have a prostate biopsy.
Research scientist Stephen Van Den Eeden, PhD, is a co-founder of the California Men's Health Study, one of the largest and longest-running cohort studies of men in the world.
Kaiser Permanente researcher receives $4.5 million from the National Cancer Institute to study link between inflammation in the breast’s fatty tissue and breast cancer outcomes.
David Baer, MD, cofounded the KP Oncology Clinical Trials program in the 1980s. He has enrolled significant numbers of patients in these trials, and helped expand the regional effort into a national KP program. As a leading member of the Northern California Central Research Committee for most of his career, he provides valuable experience in the practicality of research within Kaiser Permanente.
New research from Kaiser Permanente finds that post-menopausal women with colorectal cancer were more likely to die from their disease or from any cause if they had low social support before diagnosis.
In the years after the U.S. Preventive Services Task Force recommended against PSA-based screening in all men, many fewer men were diagnosed with prostate cancer but more were found to have advanced cancers, according to a large Kaiser Permanente study published today in the Journal of General Internal Medicine.
Women with greater adiposity, or body fatness, were significantly less likely to receive all of the recommended chemotherapy dose to treat their breast cancer, and they were subsequently 30% more likely to die from the disease as a result, according to research published in JAMA Oncology.
5 Questions for…Dr. Michael A. Bookman, co-leader of a clinical trial that could provide an important new treatment option for women with advanced gynecological cancers.